Insider Transactions in Q2 2021 at Regenxbio Inc. (RGNX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Olivier Danos Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
555
+2.75%
|
$18,315
$33.02 P/Share
|
|
Jun 25
2021
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
1,500
-0.53%
|
$60,000
$40.25 P/Share
|
|
Jun 25
2021
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+0.53%
|
$4,500
$3.76 P/Share
|
|
Jun 24
2021
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct |
4,500
-1.58%
|
$180,000
$40.02 P/Share
|
|
Jun 24
2021
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+1.55%
|
$13,500
$3.76 P/Share
|